MedPath

Effects of Nonpharmacological Interventions in Sleep Quality, Anxiety, and Delirium for Patients of Adult Intensive Care Units

Not Applicable
Not yet recruiting
Conditions
Intensive Care Unit
Critical Care
Sleep Quality
Delirium
Anxiety
Registration Number
NCT06774599
Lead Sponsor
Chiayi Christian Hospital
Brief Summary

This study will investigate the effect of nonpharmacological intervention in sleep quality, anxiety and delirium among adult ICU patients.

Detailed Description

Background: Due to the intensive care unit (ICU) noisy environment, nearly 66% critically ill patientsseem to suffer from poor sleep quality, which can easily lead to complications, such as anxiety, delirium, prolong hospital stay, and even increased mortality.

Objective: This study will investigate the effect of nonpharmacological intervention in sleep quality, anxiety and delirium among adult ICU patients.

Methods: The design of this study is a randomized experimental study recruiting 154 patients from five adult ICUs in a teaching hospital located in the central southern Taiwan. The experimental group (n=77, nonpharmacological intervention, and the control group (n=77, routine care). The nonpharmacological intervention involves listening of 30 mins ocean wave music, aromatherapy of lavender essential oil, and eye masks and earplugs. Research measurement tools, including demographic data, physiological index questionnaire, Richards-Campbell sleep scale (RCSQ), Chinese Visin-style sleep scale, Chinese State -Trait Anxiety Inventory-1, visual analogue scale for anxiety, which will be measured five times, before intervention (T1), every 9AM for three days (T2, T3, T4), and ICU transferring day (T5). SPSS 26.0 will be used to analyze data by using descriptive statistics, chi-square test, pearson correlation, independent t-test, paired t-test, ANOVA, generalized estimating equation (GEE).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
154
Inclusion Criteria
  • Conscious and able to speak or write (GCS ≥ 11)
  • Hemodynamically stable
  • Normal hearing and able to communicate in a low voice
  • Stay in ICU for more than 24 hours
  • Aged over 18 years.
Exclusion Criteria
  • Pre-existing insomnia diagnosis with long-term reliance on sleep medication,
  • Sleep-related medical history such as sleep apnea
  • Shift work prior to hospitalization
  • Diagnosis of alcohol abuse or schizophrenia
  • End-of-life or terminal conditions
  • Allergy to essential oils
  • Exclusion of dementia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sleep Quality1To record the sleep quality at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.

The investigator records the sleep quality using Richards-Campbell sleep scale

Sleep Quality2To record the sleep quality at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.

The investigator records the sleep quality using Verran sleep scale

Anxiety1To record the anxiety at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.

The investigator records the degree of anxiety using the spielberger state- trait anxiety inventory

Anxiety2To record the anxiety at 5 times, T1: the time before treatment; T2-T4: the following three days after treatment; T5: the day leaving ICU.

The investigator records the degree of anxiety using the Visual analogue scale.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath